Insulet
PODD
#1143
Rank
HK$128.57 B
Marketcap
HK$1,834
Share price
-0.37%
Change (1 day)
37.15%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): HK$2.39 B

According to Insulet's latest financial reports the company's current earnings (TTM) are HK$2.38 B. In 2023 the company made an earning of HK$1.95 B an increase over its 2022 earnings that were of HK$0.33 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$2.39 B22.49%
2023 HK$1.95 B481.9%
2022 HK$0.33 B-45.24%
2021 HK$0.61 B43.35%
2020 HK$0.42 B18.51%
2019 HK$0.36 B41.16%
2018 HK$0.25 B-711.95%
2017 -HK$41.81 M-56.85%
2016 -HK$96.9 M-79.31%
2015 -HK$0.47 B63.85%
2014 -HK$0.29 B31.04%
2013 -HK$0.22 B-21.96%
2012 -HK$0.28 B
2010 -HK$0.27 B-42.38%
2009 -HK$0.47 B-33.56%
2008 -HK$0.7 B65.93%
2007 -HK$0.42 B209.75%
2006 -HK$0.14 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$57.24 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.07 B-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.43 B 169.70%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$158.02 B 6,518.67%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$50.73 B 2,025.04%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$44.00 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$70.07 B 2,834.80%๐Ÿ‡บ๐Ÿ‡ธ USA